3 completed. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow tacedinaline: new trials by email Literature Review of tacedinaline trials Research Report on tacedinaline
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Gemcitabine With or Without CI-994 in Treating Patients With Advanced Non-small Cell Lung Cancer gemcitabine hydrochloride, tacedinaline - Lung Cancer | Phase 3 | Completed | Pfizer | 1999-12-01 | 2012-08-10 | |
| Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer gemcitabine hydrochloride, tacedinaline - Pancreatic Cancer | Phase 2 | Completed | Pfizer | 1999-10-01 | 2012-08-10 | |
| CI-994 in Treating Patients With Advanced Myeloma CI-994 - Multiple Myeloma | Phase 2 | Completed | H. Lee Moffitt Cancer Center and Research Institute | 6 | 1997-08-01 | 2012-09-25 |
Carcinoma, Non-Small-Cell Lung (1) · Lung Neoplasms (1) · Multiple Myeloma (1) · Neoplasms, Plasma Cell (1) · Pancreatic Neoplasms (1)
Pfizer (2) · H. Lee Moffitt Cancer Center and Research Institute (1)
United States (3) · Canada (2)
Kathryn Kimmel, PhD (1) · Kathy M. Diener, PharmD (1) · Melissa Alsina, M.D. (1)